Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/05/24 → 30/04/29 |
Funding
- MEDICAL RESEARCH COUNCIL (MRC): £135,778.81
MRC - A benefit-risk trial of 1-month rifapentine and isoniazid to prevent tuberculosis and reduce morbidity in people with non-communicable multimorbidity
- WALKER, SIMON MARK (Principal investigator)
- REVILL, PAUL (Co-investigator)
Project: Research project (funded) › Research